Opportunity Information: Apply for PAR 12 298
Apply for PAR 12 298
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.397 Cancer Centers Support Grants.
- This funding opportunity was created on Nov 7, 2013 and posted on Sep 26, 2012.
- Applicants must submit their applications by Nov 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Cancer Center Support Grants (CCSGs) program is a National Cancer Institute (NCI) funding opportunity under the NIH P30 mechanism designed to support NCI-designated Cancer Centers. The announcement (Funding Opportunity Number PAR-12-298) allows institutions to apply for new awards, renewals, resubmissions, or revisions. At its core, the CCSG is not meant to function like a typical project grant focused on a single research question. Instead, it is intended to strengthen and organize a whole cancer research enterprise within an institution, helping it operate as a coordinated, high-impact center that can accelerate discovery and translate findings into better approaches for cancer prevention, diagnosis, and treatment.
The FOA supports two categories of NCI-designated centers. The first is the Comprehensive Cancer Center, which is expected to show strong depth and breadth across three major scientific areas: basic laboratory research, clinical research, and prevention/control/population-based research. Comprehensive Cancer Centers must also demonstrate substantial transdisciplinary work that actively bridges these areas, meaning the science is integrated rather than siloed. The second category is the Cancer Center, which may focus primarily on basic, clinical, and/or prevention, cancer control, and population-based research, or a combination of these components, without necessarily meeting the full breadth expectations required for the comprehensive designation. In both cases, the overarching goal is to bring together all relevant cancer-related capabilities across the institution and unify them into a single, collaborative, transdisciplinary program.
A central expectation of CCSG-supported centers is that they serve as major engines of discovery and progress in the cancer field. The FOA emphasizes that these centers should contribute meaningfully to understanding the nature of cancer and to developing more effective strategies for prevention, early detection, diagnosis, and therapy. Beyond generating knowledge, centers are expected to function as organizational hubs that make high-quality research more feasible and more efficient across the institution. This typically involves strengthening the infrastructure that supports research, coordinating scientific direction across programs, and fostering collaborations that would be difficult to maintain without a formal, well-supported center structure.
Another major emphasis in the announcement is the development and support of shared resources that enable cancer research. While the FOA text provided does not list individual cores, the intent is clear: the CCSG helps create and maintain centralized capabilities that investigators across the center can access, improving quality, consistency, cost-effectiveness, and speed. These shared resources are part of what allows an NCI-designated center to operate as a unified research enterprise rather than a collection of independent labs and projects.
The FOA also highlights expectations around collaboration and coordination beyond the institution itself. CCSG-supported centers are expected to coordinate their research efforts with other NCI-funded programs and investigators, reinforcing the idea that NCI-designated centers play a national role in the cancer research ecosystem. In addition, the centers are expected to disseminate research findings for the benefit of the community, reflecting a public-facing responsibility to ensure that knowledge and advances do not remain confined to academic settings and that communities ultimately benefit from the work being supported.
From an administrative standpoint, this is a discretionary grant opportunity offered by the National Institutes of Health, specifically NCI, under CFDA 93.397 (Cancer Centers Support Grants). Cost sharing or matching is not required. Eligible applicants include a broad range of U.S.-based higher education institutions (public and private) and nonprofit organizations (including those with and without 501(c)(3) status, as specified), with additional eligibility explicitly noting Alaska Native and Native Hawaiian Serving Institutions, Hispanic-Serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible; foreign components as defined by NIH policy are not allowed.
Key dates in the source information include a posted date of September 26, 2012, with the record showing an original closing date of January 7, 2016, and an archive date of December 7, 2013 (indicating the specific listing was later archived). Applicants are directed to the full announcement for complete details at the NIH Grants Guide link provided in the source text. For technical issues accessing the announcement or linking to it, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
FAQs: Cancer Center Support Grants (CCSGs) - NCI (NIH P30) | PAR-12-298
What is the Cancer Center Support Grants (CCSGs) program?
The Cancer Center Support Grants (CCSGs) program is a National Cancer Institute (NCI) funding opportunity under the NIH P30 mechanism that supports NCI-designated Cancer Centers. It is intended to strengthen and organize an institution's overall cancer research enterprise so it operates as a coordinated, high-impact center.
What is the Funding Opportunity Number (FOA) for this announcement?
The Funding Opportunity Number is PAR-12-298.
What type of NIH grant mechanism is used for this opportunity?
This opportunity uses the NIH P30 mechanism.
Who is the sponsoring agency for this grant opportunity?
The sponsoring agency is the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI).
What is the CFDA number associated with this program?
The CFDA listing is 93.397 (Cancer Centers Support Grants).
Is the CCSG intended to fund a single research project?
No. The CCSG is not meant to function like a typical project grant focused on a single research question. It is designed to support and enhance a whole cancer center enterprise within an institution, including its organization, infrastructure, coordination, and shared resources.
What is the main purpose of a CCSG-supported center?
The core purpose is to strengthen and unify an institution's cancer-related capabilities into a collaborative, transdisciplinary center that accelerates discovery and helps translate findings into better approaches for cancer prevention, diagnosis, and treatment.
What categories of NCI-designated centers are supported under this FOA?
The FOA supports two categories: (1) Comprehensive Cancer Centers and (2) Cancer Centers.
What is expected of a Comprehensive Cancer Center under this FOA?
A Comprehensive Cancer Center is expected to demonstrate strong depth and breadth across three major scientific areas: basic laboratory research, clinical research, and prevention/control/population-based research. It must also demonstrate substantial transdisciplinary work that actively bridges these areas, with integrated (not siloed) science.
What is expected of a Cancer Center (non-comprehensive) under this FOA?
A Cancer Center may focus primarily on basic, clinical, and/or prevention, cancer control, and population-based research, or some combination of these components, without necessarily meeting the full breadth expectations required for the comprehensive designation.
What does the FOA mean by "transdisciplinary" work?
In this context, transdisciplinary work means the center's science actively bridges major research areas (such as basic, clinical, and prevention/population research) so the work is integrated across disciplines rather than separated into disconnected silos.
What broader role should CCSG-supported centers play in cancer research?
CCSG-supported centers are expected to serve as major engines of discovery and progress by contributing to understanding the nature of cancer and developing more effective strategies for prevention, early detection, diagnosis, and therapy.
How does the CCSG strengthen research at an institution?
The FOA emphasizes that CCSGs help centers function as organizational hubs by strengthening infrastructure that supports research, coordinating scientific direction across programs, and fostering collaborations that are difficult to sustain without a formal center structure.
Does this FOA emphasize shared resources?
Yes. A major emphasis is the development and support of shared resources that investigators across the center can access, improving research quality, consistency, cost-effectiveness, and speed. While the provided text does not list specific cores, the intent is to support centralized capabilities used across the cancer research enterprise.
Are CCSG-supported centers expected to collaborate beyond their own institution?
Yes. The FOA highlights expectations that centers coordinate research efforts with other NCI-funded programs and investigators, reinforcing that NCI-designated centers play a national role in the cancer research ecosystem.
Is there an expectation to share findings with the broader community?
Yes. Centers are expected to disseminate research findings for the benefit of the community, reflecting a responsibility to ensure advances and knowledge benefit communities and are not limited to academic settings.
What types of applications does the FOA allow?
The announcement allows institutions to apply for new awards, renewals, resubmissions, or revisions.
Is cost sharing or matching required?
No. Cost sharing or matching is not required for this opportunity.
What types of organizations are eligible to apply?
Eligible applicants include a broad range of U.S.-based higher education institutions (public and private) and nonprofit organizations (including those with and without 501(c)(3) status, as specified in the source information). The eligibility list also explicitly notes Alaska Native and Native Hawaiian Serving Institutions, Hispanic-Serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and related institution types named in the announcement summary.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply.
Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations are not eligible under this opportunity.
Are foreign components allowed under NIH policy for this FOA?
No. Foreign components (as defined by NIH policy) are not allowed.
When was this opportunity posted?
The posted date listed in the source information is September 26, 2012.
What closing date is shown for this listing?
The record shows an original closing date of January 7, 2016.
Is this opportunity archived?
Yes. The archive date listed is December 7, 2013, indicating the specific listing was later archived.
Where should applicants go for the full announcement and complete details?
Applicants are directed to the full announcement in the NIH Grants Guide at the link provided in the source text for complete details.
Who should be contacted for technical issues accessing the announcement link?
For technical issues accessing the announcement or linking to it, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Is this grant described as discretionary?
Yes. The source information describes it as a discretionary grant opportunity offered by NIH/NCI.
Browse more opportunities from the same category: Education Health
Next opportunity: Higher Education Challenge Grants Program
Previous opportunity: Mechanism for Time Sensitive Drug Abuse Research (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 298
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 298) also looked into and applied for these:
| Funding Opportunity |
|---|
| FY 2013 American Schools and Hospitals Abroad (ASHA) Program Worldwide Apply for APS ASHA 13 000001 Funding Number: APS ASHA 13 000001 Agency: Agency for International Development Category: Education Health Funding Amount: $2,000,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13) Apply for PAR 13 014 Funding Number: PAR 13 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Prescription Drug Abuse (R01) Apply for PA 13 015 Funding Number: PA 13 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Prescription Drug Abuse (R21) Apply for PA 13 016 Funding Number: PA 13 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21) Apply for RFA CA 13 001 Funding Number: RFA CA 13 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33) Apply for RFA CA 13 002 Funding Number: RFA CA 13 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Early Stage Development of Innovative Technologies for Biospecimen Science (R21) Apply for RFA CA 13 003 Funding Number: RFA CA 13 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Biospecimen Science (R33) Apply for RFA CA 13 004 Funding Number: RFA CA 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Limited Competition Palliative Care Research Co Operative (PCRC) (U24) Apply for RFA NR 13 004 Funding Number: RFA NR 13 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) Apply for PAR 13 036 Funding Number: PAR 13 036 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA NS 13 007 Funding Number: RFA NS 13 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS and Cancer Specimen Resource (ACSR) (UM1) Apply for RFA CA 13 005 Funding Number: RFA CA 13 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R01) Apply for PAR 13 048 Funding Number: PAR 13 048 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R21) Apply for PAR 13 049 Funding Number: PAR 13 049 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Pain in Aging (R01) Apply for PA 13 058 Funding Number: PA 13 058 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pain in Aging (R21) Apply for PA 13 059 Funding Number: PA 13 059 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Pain in Aging (R03) Apply for PA 13 060 Funding Number: PA 13 060 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Administrative Supplements to NCI Funded Research Projects Funding to Advance Research on Cancers in Women (Admin Supp) Apply for PAR 13 067 Funding Number: PAR 13 067 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20) Apply for PAR 13 068 Funding Number: PAR 13 068 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Dissemination and Implementation Research in Health (R21) Apply for PAR 13 054 Funding Number: PAR 13 054 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 298", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.